✦ LIBER ✦

Evidence of B Cell Immune Responses to Acute Lymphoblastic Leukemia in Murine Allogeneic Hematopoietic Stem Cell Transplantation Recipients Treated with Donor Lymphocyte Infusion and/or Vaccination

✍ Scribed by Craig A. Mullen; Andrew Campbell; Olena Tkachenko; Johan Jansson; Yu-chiao Hsu

Book ID: 116281897
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 760 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.08.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot study of prophylactic donor lymp

A pilot study of prophylactic donor lymphocyte infusions to prevent relapse in adult acute lymphoblastic leukemias after allogeneic hematopoietic stem cell transplantation

✍ Lutz, C; Massenkeil, G; Nagy, M; Neuburger, S; Tamm, I; Rosen, O; Dörken, B; Arn 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 161 KB

Case of a patient with Philadelphia-chro

Case of a patient with Philadelphia-chromosome-positive acute lymphoblastic leukemia relapsed after myeloablative allogeneic hematopoietic stem cell transplantation treated successfully with imatinib and sequential donor lymphocyte infusions

✍ Makoto Yoshimitsu; Hiroshi Fujiwara; Atsuo Ozaki; Heiichiro Hamada; Kakushi Mats 📂 Article 📅 2008 🏛 Carden Jennings Publishing 🌐 English ⚖ 163 KB

The value of monitoring minimal residual

The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

✍ Xiao Ma; Depei Wu; Aining Sun; Huiying Qiu; Zhenzhen Fu; Xiaojin Wu; Suning Chen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

Nilotinib and donor lymphocyte infusion

Nilotinib and donor lymphocyte infusion in the treatment of Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL) relapsing after allogeneic stem cell transplantation and resistant to imatinib

✍ Mario Tiribelli; Alessandra Sperotto; Anna Candoni; Erica Simeone; Silvia Buttig 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 223 KB

40 Long term comparison of relapse and o

40 Long term comparison of relapse and overall survival in patients with chronic myeloid leukemia (CML) and acute lymphocytic leukemia (all) treated with unrelated or related donor allogeneic marrow/stem cell transplantation

✍ S.A. Al-Sukbun; E. Abella; R.D. Baynes; C. Karanes; R.D. Dansey 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Combining Azacitidine (Vidaza®, Aza) and

Combining Azacitidine (Vidaza®, Aza) and Donor Lymphocyte Infusions (DLI) as First Salvage Treatment in Patients (PTS) With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS) Relapsing After Allogeneic Hematopoietic Stem Cell Transplantation (allo-SCT): Interim-Analysis From the Azarela-Trial (NCT-00795548)

✍ T. Schroeder; A.G. Czibere; N. Kröger; U. Platzbecker; G. Bug; L. Uharek; T. Luf 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB